Highlights

Van Gogh of Financial

Author: newbie8080   |   Latest post: Wed, 18 Nov 2020, 11:37 PM

 

Coronavirus likely to become as ‘endemic’ as flu-Vaccine might not be able to stop it

Author:   |    Publish date:


Coronavirus likely to become as ‘endemic’ as the flu and a vaccine might not be able to stop it, top UK scientist says

 

  • Covid-19 is likely to become as “endemic” as the annual flu virus, according to the U.K.’s chief scientific advisor.

 

  • A vaccine is not likely to eradicate the virus, the advisor cautioned.

Health workers are dressing with protective suits and face maks. The collection of swab samples by medical staff in the drive-in testing center of San Filippo Neri hospital in Roma, Italy on October 19, 2020.

 

LONDON — Covid-19 is likely to become as “endemic” as the annual flu virus, according to the U.K.’s chief scientific advisor.

Some potential vaccines are in late-stage clinical trials, but Patrick Vallance said none is likely to eradicate the virus.

“The notion of eliminating Covid from anywhere is not right, because it will come back,” he said, noting there had only been one human disease “truly eradicated” thanks to a highly effective vaccine and that was smallpox.

“We can’t be certain, but I think it’s unlikely we will end up with a truly sterilizing vaccine, (that is) something that completely stops infection, and it’s likely this disease will circulate and be endemic, that’s my best assessment,” Vallance told the National Security Strategy Committee in London on Monday.

“Clearly as management becomes better, as you get vaccination which would decrease the chance of infection and the severity of disease ... this then starts to look more like annual flu than anything else, and that may be the direction we end up going,” he said.

Biotech companies and academic bodies around the world have joined forces to try to create a vaccine against the coronavirus at breakneck speed given its ferocity. On Monday, the grim milestone of 40 million confirmed coronavirus cases worldwide was reached, and the virus has caused 1.1 million deaths, according to data from Johns Hopkins University.

Historically, creating a vaccine from scratch had taken 10 years on average, Vallance said, and it had never taken under five years.

“We’re now in the extraordinary situation where there are at least eight vaccines which are in quite large clinical studies around the world. ... We will know over the next few months whether we have any vaccines that really do protect and how long they protect for,” he said.

He added that a number of vaccines created an immune response and antibody response, but only the Phase 3 clinical trials would prove whether they “actually stop people getting infected.” The safety profile of such vaccines would also become clearer and from then on, a “sensible vaccination strategy” could be looked at, Vallance said.

Vallance concluded he didn’t believe there would be any vaccine available for widespread use in the community until at least spring.

 

Coronavirus in the US for comparison

 

 

 

Will Topglove be able to remain top glove manufacturer?

 

Will Supermax be able to defend market share with their OBM method?

 

Will Hartalega up its ante to recover back lost time?

 

Will Kossan be able to claw back it’s marker share?

 

Will Sri Trang going to expand capacity to defend Thai’s pride?

 

 

Share this

  Be the first to like this.
 
sensonic I WILL CONTINUE TO BUY TOP GLOVES AND SUPERMAX TOMORROW. THANKS FOR YOUR INFO.
20/10/2020 11:33 PM
newbie8080 Five South Koreans die after getting flu shots, sparking vaccine fears

https://www.reuters.com/article/health-coronavirus-southkorea-flushots/five-south-koreans-die-after-getting-flu-shots-sparking-vaccine-fears-idUSL4N2HC0QA
21/10/2020 5:05 PM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

529  557  546  538 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 KANGER 0.185+0.005 
 AT 0.200.00 
 BINTAI 0.795+0.10 
 KGROUP 0.060.00 
 MTRONIC 0.115+0.005 
 ASIABIO-OR 0.015+0.005 
 IRIS 0.36+0.005 
 VIVOCOM 1.01+0.205 
 FINTEC 0.105+0.01 
 SOLUTN 1.27+0.15 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!
PARTNERS & BROKERS